FUNCTIONAL AREAS – Page 10

Inconsistent SOP interpretation during regulatory inspection readiness – CAPA effectiveness verification framework

Identifying symptoms associated with inconsistent SOP interpretation is critical for initiating a thorough investigation. These symptoms can manifest as:Click to read the full article.

Audit finding not escalated during QA review – FDA/MHRA inspector questions to prepare for

The first step in any investigation is to recognize the symptoms or signals indicating an underlying issue. The following points are critical indicators that suggest audit findings may not have…

Supplier deviation not assessed during batch release decision – FDA/MHRA inspector questions to prepare for

Identifying symptoms or signals of supplier deviations is the first step in addressing this critical issue. Common signs may include:Click to read the full article.

Batch disposition delayed during QA review – FDA/MHRA inspector questions to prepare for

Addressing Delays in Batch Disposition During QA: A Comprehensive Investigation Framework In pharmaceutical operations, timely batch disposition is critical for ensuring product availability and compliance with regulatory standards. Delays during…

Deviation closed without effectiveness check during QA review – GDP documentation do’s and don’ts

Identifying symptoms associated with deviations closed without an effectiveness check is critical for timely resolution. Symptoms may manifest as increased batch rejections, an uptick in customer complaints, or higher levels…

Batch disposition delayed during regulatory inspection readiness – GDP documentation do’s and don’ts

Symptoms signaling potential delays in batch disposition can originate from various processes within the pharmaceutical manufacturing lifecycle. Below are common signals that should heighten awareness:Click to read the full article.

Deviation closed without effectiveness check during complaint triage – CAPA effectiveness verification framework

Recognizing symptoms or signals promptly is the first step in managing a deviation effectively. These signals can emerge through various channels such as internal quality checks, routine audits, or complaints…

Inconsistent SOP interpretation during QA review – risk-based justification template for decisions

Recognizing symptoms of inconsistent SOP interpretation is crucial for initiating a timely investigation. Typical signals include:Click to read the full article.

Supplier deviation not assessed during management review – GDP documentation do’s and don’ts

Identifying the signals that indicate a supplier deviation may have gone unassessed is crucial for early intervention. Common symptoms include:Click to read the full article.

CAPA overdue beyond target date during complaint triage – risk-based justification template for decisions

Addressing CAPA Delays Beyond Target Dates During Complaint Triage In the highly regulated pharmaceutical industry, timely corrective and preventive actions (CAPA) are crucial to maintaining compliance and ensuring product quality.…

Batch disposition delayed during change control governance – GDP documentation do’s and don’ts

When batch disposition delays occur, certain symptoms or signals may become apparent on the production floor or within the laboratory environment. Recognizing these indicators early can help teams respond appropriately…

Audit finding not escalated during internal audit follow-up – risk-based justification template for decisions

When an audit finding is not escalated, several symptoms may manifest on the shop floor or within laboratory operations. Some indications that a significant issue has not been adequately addressed…